Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Browse by Warwick Author

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Official Date | Item Type | Funder | No Grouping
Jump to: AstraZeneca (Firm) | BUPA Foundation | Boehringer Ingelheim Pharmaceuticals | Cochrane Collaboration | Collaborations for Leadership in Applied Health Research and Care (CLAHRC) | London School of Hygiene and Tropical Medicine‏ | National Institute for Health Research (Great Britain) (NIHR) | Novartis (Firm) | University Hospitals Birmingham NHS Foundation Trust | Warwick Medical School | World Heart Federation. Emerging Leaders Program
Number of items: 11.

AstraZeneca (Firm)

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

BUPA Foundation

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

Boehringer Ingelheim Pharmaceuticals

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

Cochrane Collaboration

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

Collaborations for Leadership in Applied Health Research and Care (CLAHRC)

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

London School of Hygiene and Tropical Medicine‏

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

National Institute for Health Research (Great Britain) (NIHR)

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

Novartis (Firm)

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

University Hospitals Birmingham NHS Foundation Trust

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

Warwick Medical School

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

World Heart Federation. Emerging Leaders Program

Bahiru, Ehete, De Cates, Angharad N., Farr, Matthew R. B., Jarvis, Morag, Palla, Mohan, Rees, Karen, Ebrahim, Shah and Huffman, Mark D. (2017) Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases. Cochrane Database of Systematic Reviews (3). CD009868. doi:10.1002/14651858.CD009868.pub3 ISSN 1469-493X.

This list was generated on Mon Mar 20 16:01:54 2023 GMT.
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us